BD1 Outlook, page-140

One thing I will guarantee you is it will go up and down....they all do.

I provided reasons why I think BD1 will be worth more in 12 months than it is today.

Some have suggested BD1 is a pure punt, I tend to disagree they have consistently shifted the ball forward. Ovarian trials have only gotten more accurate.....I suspect breast/lung cancer will be the same.

CR out the way plenty of cash as they are quite thrifty.

Thermo Fisher a 90 billion USD company quite happy for luminex tech to be the assay method, which IMO is a big nod.

The vaccine trials are due any time now and clearly management thought it was worth while going to live trials......my point is lab results must have been good enough to warrant this. 

I eagerly await the outcome....I don't believe the sp has any downside in it from a vaccine point as most think its a dream but hold on to yr hat if it fires up the immune system or heaven forbid actually cured some cancer......the breast test 7c will look pedestrian IMO. DB